JANUS HENDERSON GROUP PLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for BENITEC BIOPHARMA INC. (BNTC)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
BENITEC BIOPHARMA INC. Common Stock
Symbol
BNTC
Shares outstanding
23.2M shares
Disclosed Ownership
2.62M shares
Ownership
11.3%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 12:37 PM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 11.3% 2.62M 0 2.62M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 8.6% 1.98M 0 1.98M Kristin Mariani Head of North America Compliance, CCO